NDFIP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.798990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.556100E-02
Normal-vs-Stage2
1.703580E-01
Normal-vs-Stage3
7.051000E-01
Normal-vs-Stage4
2.094600E-01
Stage1-vs-Stage2
6.882600E-01
Stage1-vs-Stage3
5.335600E-02
Stage1-vs-Stage4
7.836400E-01
Stage2-vs-Stage3
2.570200E-01
Stage2-vs-Stage4
8.947200E-01
Stage3-vs-Stage4
1.579950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.740760E-01
Normal-vs-AfricanAmerican
2.241000E-01
Normal-vs-Asian
3.141400E-01
Caucasian-vs-AfricanAmerican
3.533400E-01
Caucasian-vs-Asian
9.324800E-01
AfricanAmerican-vs-Asian
3.297000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.725970E-01
Normal-vs-Female
1.982800E-01
Male-vs-Female
6.578000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.976200E-01
Normal-vs-Age(41-60Yrs)
1.207400E-01
Normal-vs-Age(61-80Yrs)
2.389800E-01
Normal-vs-Age(81-100Yrs)
1.948850E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.484600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.618200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.061000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.820200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.706000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.508600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.901000E-01
Normal-vs-Daily Drinker
3.391800E-01
Normal-vs-Weekly Drinker
5.355600E-01
Normal-vs-Occasional Drinker
4.902500E-02
Normal-vs-Social Drinker
1.417960E-01
Non Drinker-vs-Daily Drinker
8.632600E-01
Non Drinker-vs-Weekly Drinker
4.423000E-01
Non Drinker-vs-Occasional Drinker
1.192360E-02
Non Drinker-vs-Social Drinker
3.445200E-01
Daily Drinker-vs-Weekly Drinker
5.567200E-01
Daily Drinker-vs-Occasional Drinker
1.344430E-02
Daily Drinker-vs-Social Drinker
2.977400E-01
Weekly Drinker-vs-Occasional Drinker
8.419200E-03
Weekly Drinker-vs-Social Drinker
1.389350E-01
Occasional Drinker-vs-Social Drinker
1.634620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.191770E-01
Normal-vs-Grade 2
7.142700E-03
Normal-vs-Grade 3
6.484000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.150200E-01
Grade 1-vs-Grade 3
2.809400E-01
Grade 1-vs-Grade 4
1.191770E-01
Grade 2-vs-Grade 3
1.813040E-01
Grade 2-vs-Grade 4
7.142700E-03
Grade 3-vs-Grade 4
6.484000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.125200E-01
Normal-vs-NonDiabetic
1.388560E-01
Diabetic-vs-NonDiabetic
5.829600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.508200E-01
Normal-vs-NoPancreatitis
1.845200E-01
Pancreatitis-vs-NoPancreatitis
6.639000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.680190E-01
Normal-vs-N1
1.816600E-01
N0-vs-N1
9.517000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.631600E-02
Normal-vs-TP53-NonMutant
2.632200E-01
TP53-Mutant-vs-TP53-NonMutant
5.781100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
